Dr David Dodwell
BSc, MD, FRCP, FRCR
Senior Clinical Research Fellow
I am a senior breast oncologist based in Leeds with a number of research and governance activities. I am the lead oncologist on the Sloane, NHS screening & national HQIP breast cancer audits.
I am a senior clinical research fellow to the EBCTCG and a member of steering groups for 12 ongoing UK trials in breast cancer. I sit on the trial management committees for 3 trials.
I am UK lead for the SACT project (UK chemotherapy database) and chair the clinical group, which provides input and advice to this project to examine the safety, efficacy and cost-effectiveness of chemotherapy used in England.
Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
Maxwell AJ. et al, (2018), Eur J Surg Oncol, 44, 429 - 435
Impact of radiotherapy and endocrine therapy on further events: Final multivariate analysis of a prospective, national cohort study of screen detected ductal carcinoma in situ (DCIS) of the breast
Thompson AM. et al, (2018), CANCER RESEARCH, 78
A longitudinal cohort study to identify risk factors for the development of invasive cancer in unresected DCIS
Maxwell AJ. et al, (2018), CANCER RESEARCH, 78
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39
Making progress in early breast cancer: Taking time or accepting risk?
Mannu GS. and Dodwell D., (2017), Eur J Cancer, 78, 24 - 27